Neogenomics NEO
NASDAQ NEO
$19.14 -0.27 (-1.42%)
As of: Sep 22, 2026 · 10:53 AM EDT

Neogenomics (NEO) Cash & Equivalents Growth (5y) (2015 - 2026)

Analysis

Neogenomics (NEO) Cash & Equivalents Growth (5y) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.97%
Mar 31, 2026 -24.91%
Dec 31, 2025 -6.94%
Sep 30, 2025 -6.79%
Jun 30, 2025 -12.13%
Mar 31, 2025 32.04%
Dec 31, 2024 16.23%
Sep 30, 2024 15.14%
Jun 30, 2024 16.22%
Mar 31, 2024 90.60%
Dec 31, 2023 103.51%
Sep 30, 2023 20.92%
Jun 30, 2023 98.27%
Mar 31, 2023 78.58%
Dec 31, 2022 83.01%
Sep 30, 2022 85.21%
Jun 30, 2022 91.78%
Mar 31, 2022 94.34%
Dec 31, 2021 90.81%
Sep 30, 2021 63.74%
API Access

Neogenomics Cash & Equivalents Growth (5y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-5y&ticker=NEO&period=max&api_key=YOUR_API_KEY